Artificial neural networks in cancer research

Pathobiology

Volumn 65, Issue 3, 1997, Pages 129-139

  Naguib, R N G ^a   Sherbet, G V ^b  

^a Department of Electrical and Electronic Engineering ^*  (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Bladder cancer; Breast cancer; DNA ploidy; Hodgkin's disease; Image cytometry; Liver cancer; Lung cancer; Lymph nodes; Multivariate analysis; Neural networks; Prognosis; Prostate cancer; S phase fraction; Testicular cancer

Indexed keywords

TUMOR MARKER;

ARTICLE; ARTIFICIAL NEURAL NETWORK; BRAIN FUNCTION; BREAST CANCER; CANCER; CANCER DIAGNOSIS; CANCER RESEARCH; HUMAN; IMAGE CYTOMETRY; LYMPH NODE METASTASIS; MATHEMATICAL MODEL; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER;

EID: 0030756045     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000164114     Document Type: Article

References (53)

1. Narus SP. Kiick K, Westenskow DR: Intelligent monitor for an anaesthesia breathing circuit. Proc Annu Symp Comput Application Med Care 1995:96-100.
2. Wu YC. Doi K. Giger ML: Detection of lung nodules in digital chest radiographs using artificial neural networks: A pilot study. J Digit imaging 1995;8(2):88-94.
3. Keem S. Meadows H. Kemp H: Hierarchical neural networks in quantitative coronary arteriography. Proc IEEE Ini Conf Artif Neural Networks 1995:459-464.
4. Andrae MH: Neural networks and early diagnosis of myocardial infarction. Lancet 1996: 347:407-408.
5. Dumitra A. Radulescu E. Lazarescu V: Improved classification of psychiatric mood disorders using a feedforward neural network. Medinfo 1995:8:818-822.
6. Moreno L, Pinero JD. Sanchez JL. Manas J. Acosta L. Hamilton A: Brain maturation using neural classifier. IEEE Trans Biomed Eng 1995:42:428-432.
7. Fausett L: Fundamentals of Neural Networks-Architectures. Algorithms and Applications. Englewood Cliffs, Prentice-Hall. 1994.
8. Zurada JM: Introduction to Artificial Neural Systems. Santa Clara West Publishing, 1992.
9. Office of Population Censuses and Surveys 1993 Cancer Statistics. Registrations 1987, England and Wales. London. HMSO. Series MB 1. No. 20.
10. Gittcs RF: Carcinoma of the prostate. N Engl J Med 1991:324:236-245.
11. Snow PB. Smith DS. Catalona WJ: Artificial neural networks in the diagnosis and prognosis of prostate cancer a pilot study. J Urol 1994: 152:1923-1926.
12. Naguib RNG. Robinson MC, Neal DE. Ham-dy FC: Neural networks: a new- tool to predict outcome in prostate cancer. Eur Urol 1996; 30(2):73.
13. Neural Works Professional II/Plus Reference Guide. Pittsburgh, NeuralWare Inc. 1995.
14. Early breast cancer trialist's collaborative group: Systemic treatment of early breast cancer by hormonal cytotoxic or immune therapy. Lancet 1992:339:71-85.
15. De Laurentiis M. Ravdin PM: Survival analysis of censored data: neural network analysis detection of complex interactions between variables. Breast Cancer Res Treat 1994:32: 113-118
16. De Laurentiis M. Ravdin PM: Survival analysis of censored data: neural network analysis detection of complex interactions between variables. Breast Cancer Res Treat 1994:32: 113-118
17. Astion ML. Wilding P: Application of neural networks to the interpretation of laboratory data in cancer diagnosis. Clin Chem 1992:38/1: 34-38.
18. Choong PL. deSilva CJS: Breast cancer prognosis using the ENM architecture. Proc IEEE Int ConfNeural Networks 1994;6:3116-3120.
19. Naguib RNG. Adams AE. Horne CHW. Angus B. Sherbet GV, Lennard TWJ: Prediction of nodal metastasis and prognosis in breast cancer: A neural model. Anlicanccr Res, in press.
20. Tarasscnko L. Whitehousc R. Gasparini G. Harris L: Neural network prediction of relapse in breast cancer patients. Neural Comput Application 1996:4(2):105-113.
21. Naguib RNG. Adams AE, Home CHW. Angus B. Sherbet GV, Lennard TWJ: The detection of nodal metastasis in breast cancer using neural network techniques. Physiol Meas 1996:17: 297-303.
22. Hedley DW. Rugg C. Gelber R: Association of DNA index and S-phase fraction with prognosis of node positive early breast cancer. Cancer Res 1987:47:4729-4735.
23. Clark GM. Dressier LG, Owens MA. Pounds G, Oidaker T, McGuire W: Prediction of relapse or survival in patients with node-negative breas: cancer by DNA How' cytometry. N Engl J Med 1989:320:627-633.
24. Grant MFX. Blijham G. Reiner A. Reynder SM, Shutte B. Van Asche C. Steer G. Jekesz R: DNA ploidv and other results of DNA flow cytometry on prognostic features in operable breast cancer: 10-vear results of a random study. Eur J Cancer 1992:28:711-716.
25. Ferno M. Baldetorpe B. Borg A. Olsson H, Sigurdsson H. Killander D: Flow cytometric DNA index and S-phasc fraction in breast cancer in relation to other prognostic variables and to clinical outcome. Acta Oncol 1992:31:157-165.
26. Wenger CR, Beardslee S. Owens MA. Pounds G, Oidaker T. Vcndely P. Pandian MR. Harrington D. Clark GM. McGuire WL: DNA ploidy, S-phase. and steroid receptors in more than 127,000 breast cancer patients. Breast Cancer Res Treat 1993:28:9-20.
27. Sherbet GV, Lakshmi MS: The genetics of cancer: Genes associated with cancer invasion, metastasis and cell proliferation. London. Academic Press. 1997.
28. Lanigan DJ. McLean PA. Murphy DM. Donovan MG, Leader M: Image analysis in the determination of ploidy and prognosis in renal eell carcinoma. Eur Urol 1992;22:228-234.
29. Lipponen P. Papinaho S, Eskelincn M. Klemi PJ, Aaltomaa S. Kosma VM. Marin S, Syrjanen K: DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer. Anticancer Res 1992:12:1533-1538.
30. Fisher B. Ravdin RG. Ausman RK. Slack NH. Moore GE, Noer RJ: Surgical adjuvant chemotherapy in cancer of the breast: Results of a decade of co-operative investigation. Ann Surgery 1968:168:337-356.
31. Sulkes A. Livingston RB, Murphy WK: Tritiated thymidine labelling index and response in human breast cancer. J Natl Cancer Inst 1979:65:513-515.
32. Drewinko B. Patchen M, Yang LY. Yang YY. Bcrlogi B: Differential killing efficiency of twenty antitumour drugs on proliferating and non-proliferating human tumour cells. Cancer Res 1981;41:2328-2333.
33. Remvikos Y. Beuzeboc P. Zadela A, Voillemot N. Magdelenat H. Pouillart P: Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy. J Natl Cancer Inst 1989:81:1383-1387.
34. McGuire WL. Dressier LG: Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients. J Natl Cancer Inst 1985:75:405-410.
35. Kallioniemi OP. Blanco G, Alavaikko M. Hie-tanen T. Manila J, Lauslahti K. Lehtinen M. Koivuta M: Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer. Cancer 1988:62:2183-2190.
36. Courdi A. Henry M, Dahan E. Gioanni J. Abbes M, Monticclli J. Ettore F. Moll JL. Nem-erM: Factors affecting relapse in node-negative breast cancer. A multivariate analysis including the labelling index. Eur J Cancer Clin Oncol 1989;25:351-356.
37. Sigurdsson H, Baldetorp B. Borg A. Dalberg M. Femo M. Killander D, Olsson H: Indicator of prognosis in node-negative breast cancer. N Engl J Med 1990;322:1045-1053.
38. Vielh P. Chevillard S. Mosseri V. Donatini B, Magdelenat H: Ki67 index and S-phase fraction in human breast carcinoma. J Clin Pathol 1990:94:681-686.
39. McDcvitt RW, Stone KR. Craig RB. Palmer JO. Meyer JS. Bauer WC: A proposed classification of breast cancer based on kinetic information derived from comparison of risk factors in 168 primary operable breast cancers. Cancer 1986:57:269-276.
40. Baisch H, Beck HP. Christensen IJ. Hartmann NR, Fried J. Dean PN. Gray JW. Jett JH. Hon-ston DA. White RA. Nicolini C. Zeitz S. Watson JV: A comparison of mathematical methods for the analysis of DNA histograms obtained by flow cytometry. Cell Tissue Kind 1982:15:235-249.
41. Sigurdsson H. Baldetorp B. Borg A. Dalberg M. Femo M. Killander D, Olsson H, Ranstam J: Flow cytometry in primary breast cancer: Improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels. Br J Cancer 1990:62:786-790.
42. Lakshmi MS. Sherbet GV: Measurement of DNA content and nuclear pleomorphism in metastatic variants of the B16 murine melanoma and hamster lymphoma and its liver metastasis using image analysis techniques. Clin Exp Metastasis 1990:6:553-566.
43. Scott NA. Beatty WR Jr. Wciland LH. Cha SS. Liebcr MM: Carcinoma of the anal canal and flow cytometric DNA analysis. Br J Cancer 1989;60:56-58.
44. Tribukait B, Gustafson H. Esposti PL: The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours. A study of 100 untreated cases. Br J Urol 1982:54:130.
45. Falkmcr UG: Methodological aspects of flow and image cytometric nuclear DNA assessments in prostatic adenocarcinoma. Acta Oncol 1991:30:201-203.
46. Asada N, Doi K: Potential usefulness of an artificial neural network for differential diagnosis of interstitial lung diseases: pilot study. Radiology 1990:177:857.
47. Maclin PS. Dempsey J: A neural network to diagnose liver cancer. Proc IEEE Int Conf Neural Networks 1993:3:1492.
48. Moul JW. Snow PB. Fernandez EB, Maher PD. Sestcrhenn IA: Neural network analysis of quantitative histological factors to predict pathological stage in clinical stage 1 nonsemi-nomatous testicular cancer. J Urol 1995:153: 1674-1677.
49. Ercal F, Chawla A, Stoecker WV, Lee HC, Moss RH: Neural network diagnosis of malignant melanoma from colour images. IEEE Trans Biomcd Eng 1994:41:837-845.
50. Naguib RNG, Qureshi KN. Hamdy FC. Neal DE: Neural network analysis of prognostic markers in bladder cancer. Internal Report No. EE/3/97/SI7, Dept Electrical and Electronic Eng, Univ of Newcastle upon Tyne. 1997.
51. Naguib RNG: Identification at diagnosis and prediction of four-year prognosis of poor-risk patients under 55 years old with Hodgkin's disease- a neural model. Internal Report No. EE/ 3/97/S16. Dept Electrical and Electronic Eng. Univ of Newcastle upon Tyne. 1997.
52. Cox DR: Regression models and life-tables. J R Slat Soc [B] 1972:34:187-200.
53. Erlichman C, Warde P. Gadalla T. Ciampi A, Baskerville T: RECAMP analysis of prognostic factors in patients with stage III breast cancer. Breast Cancer ResTrcat 1990:16:231-242.